Arch Venture Partners Ix Overage, L.p. - Net Worth and Insider Trading
Arch Venture Partners Ix Overage, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arch Venture Partners Ix Overage, L.p. owns 6 companies in total, including Beam Therapeutics Inc (BEAM) , Vir Biotechnology Inc (VIR) , and Karuna Therapeutics Inc (KRTX) among others .
Insider Ownership Summary of Arch Venture Partners Ix Overage, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BEAM | Beam Therapeutics Inc | 2020-02-05 | 10 percent owner |
VIR | Vir Biotechnology Inc | 2021-03-30 | 10 percent owner |
KRTX | Karuna Therapeutics Inc | 2019-06-27 | 10 percent owner |
GOSS | Gossamer Bio Inc | 2019-02-07 | 10 percent owner |
SANA | Sana Biotechnology Inc | 2021-02-03 | 10 percent owner |
LYEL | Lyell Immunopharma Inc | 2021-06-16 | 10 percent owner |
Arch Venture Partners Ix Overage, L.p. Trading Performance
Arch Venture Partners Ix Overage, L.p. Ownership Network
Ownership Network List of Arch Venture Partners Ix Overage, L.p.
Ownership Network Relation of Arch Venture Partners Ix Overage, L.p.
Arch Venture Partners Ix Overage, L.p. Owned Company Details
What does Beam Therapeutics Inc do?
Who are the key executives at Beam Therapeutics Inc?
Arch Venture Partners Ix Overage, L.p. is the 10 percent owner of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include Chief Medical Officer Amy Simon , President & CSO Giuseppe Ciaramella , and CFO Terry-ann Burrell .
Beam Therapeutics Inc (BEAM) Insider Trades Summary
Over the past 18 months, Arch Venture Partners Ix Overage, L.p. made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 114,771 shares made by Terry-ann Burrell , a net sale of 17,788 shares made by Christine Bellon , and a net sale of 215,751 shares made by Giuseppe Ciaramella .
In summary, during the past 3 months, insiders sold 1,016,735 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 1,016,735 shares. During the past 18 months, 1,433,256 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,433,256 shares.
Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Beam Therapeutics Inc Insider Transactions
Arch Venture Partners Ix Overage, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Arch Venture Partners Ix Overage, L.p.. You might contact Arch Venture Partners Ix Overage, L.p. via mailing address: 8755 W. Higgins Road, Suite 1025, Chicago Il 60631.